PPT-TITLE: Qualitative Identification of Fentanyl and its Analogs by Use of Functionalized

Student Jonathan Adamson Mentors Dr Sunil Paliwal Dr Barry Bunin and Beth AustinDeFares Homeland Security Challenge Approach Outcomes Conclusion Acknowledgements This material is based upon work supported by the US Department of Homeland Security under Cooperative Agreement No 2014ST061ML0001 The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies either expressed or implied of the US Department of Homeland Security. By Carla Alexander, 4. th. Year Pharmacy Student. March . 15, . 2011. Pain management in the elderly differs from that for younger people:. Clinical manifestations are often complex and multi-factorial. David Pierce and Dan . Cayan. Scripps Institution of . Oceanography. Bridget Thrasher, Edwin Maurer, John . Abatzoglou. , Katherine . Hegewisch. Development sponsored by. . The California Energy Commission. Jed Wolpaw MD, . M.Ed. Classification of opioids. Naturally . Occurring. Morphine. Codeine. Papaverine. Thebaine. Semisynthetic. Heroin. Dihydromorphone. , . morphinone. Thebaine. derivatives (e.g., . October 17, 2017. Douglas C. Dorley. Public Information Officer. Drug Enforcement Administration. St. Louis Division. Methamphetamine. widely available. primary . drug threat in western Division. Mexican crystalized methamphetamine . Drug Epidemic. 197. 7. Imagine if a Plane Fell From the Sky Each Day. 72,000 deaths – 2017 - CDC. How We Got in This Mess. 1990’s – Big Pharm & the 5. th. Vital Sign. 2010 - Rapid Increase in Heroin Deaths. DEA Philadelphia Field Division. Intelligence Program. July 2018. UNCLASSIFIED. Threats. What you already know:. Pennsylvania is in the midst of a drug abuse and overdose epidemic. Prescription opioid abuse fueled heroin abuse. Update on Heroin and Fentanyl- Cuyahoga County Thomas Gilson, MD Cuyahoga County medical Examiner 49 40 64 64 91 107 184 161 1 5 0 194 198 127 114 107 117 103 98 111 116 124 115 13 16 22 40 39 36 33 . Senior Design Team sddec19-07. Olouwole Eteka,Kossi Egla, Zheyuan Tang,Ugerah Abalu,Hao Wang,Yifu Zhang. Advisor: Dr Meng Lu. Diane A. Tennies, PhD, LADC . Christy Hicks, LCSW, LADC. TEAP Regional Health Specialists . Learning Objectives. Identify the signs of . Kratom. use and intervention strategies with JC students.. Identify the symptoms associated with inhalant abuse and intervention strategies with JC students.. Laboratory. Research Overview. . Forensic Science Research Federal Stakeholders Meeting . February 2018. Jeffrey H. Comparin. Laboratory Director. Drug Enforcement Administration. Special Testing and Research Laboratory. Expanding access to harm reduction with a take home drug testing tool. REFERENCES. 1. Hansen S, Bourque K, . Migliardi. P. Test that Shit: A drug testing pilot project, Wpg. . Meet Moment Nine Circles. Optimal Management of Metastatic . Non-Small Cell Lung Cancer. Faculty. . Moderator. Neil Love, MD. Hossein . Borghaei. , DO, MS . Julie R . Brahmer. , MD. Edward B . Garon. , MD, MS. Ramaswamy Govindan, MD. Thrombectomy. Device for Acute Ischemic Stroke. Miranda Ajulufoh . Advisors: Dr. . Savastano. and Yang Liu. Department of Neurosurgery and Mechanical Engineering. University of Michigan, Ann Arbor. FOR BREAKTHROUGH CANCER . PAIN. E. DUCATION. 1. HIGH RISK MEDICINES. Objectives. Provide a brief overview of fentanyl oromucosal formulations currently available. . Describe recognised safety issues with:.